Irido-Zonulo-Hyaloidotomy With Nd-Yag Laser To Treat Malign Glaucoma In A Pseudophakic Nanophthalmic Patient
Published 2023
- 41st Congress of the ESCRS
Reference: PP23.17
| DOI:
10.82333/h2ny-3x40
Authors:
Firat Helvacioglu* 1
, Ertan Sunay 1
, Sultan Kaya Unsal 1
, Ozer Kavalcioglu 1
1Ophthalmology,Veni Vidi Eye Hospital,Istanbul,Türkiye
To evaluate the safety and efficiency of Irido-zonulo-hyaloidotomy with Nd-YAG laser to treat malign glaucoma in a pseudophakic nanophthalmic patient.
Veni Vidi Eye Hospital, Istanbul, Turkey.
The nanophthalmic patient came to our clinic with symptoms of angle closure glaucoma. Initially Nd- YAG laser iridotomies were performed at 12 O’clok in ODS. The IOP was under control in OD but since the IOP was still high in OS, clear lens extraction and monofocal IOL implantation by phacoemulsification was performed by the aid of limited pars plana vitrectomy. Finally Nd-YAG laser irido-zonulo-hyaloidotomy was performed and anterior chamber was deepened and IOP was under control without medication in OS.
In the first visit, the IOP of the eyes were 44 and 48 under full topical anti glaucoma medications. After Nd- YAG laser iridotomies, the IOP of OD was 17 and OS was 37 respectively with topical medications. After clear lend extractraction and IOL implantation the IOP was 34. Anterior chamber was found to be still shallow (1.99 mm) in OS. After Nd-YAG laser irido-zonulo-hyaloidotomy, the anterior chamber was deepened (2.95 mm) in OS and IOP was 17 without any topical medication.
In pseudophakic nanophthalmic eyes, irido-zonulo-hyaloidotomy performed by an anterior vitrectomy probe was an important step of the surgery. Nd-YAG laser irido-zonulo-hyaloidotomy was also found to be a safe and effective alternative to this surgical step.